While the country hopes to start mass-producing the vaccine by October and plans to offer the first doses ...More

While the country hopes to start mass-producing the vaccine by October and plans to offer the first doses to essential workers, many in the science community seem unimpressed. The announcement should be taken "with a pinch of salt", said Indian immunologist Vineeta Bal. ...Less

Here’s why Russia wants to produce the coronavirus vaccine in India ...More

Here’s why Russia wants to produce the coronavirus vaccine in India ...Less

The vaccine has been developed by Siberia's Vector Institute, which completed early-stage human trials of ...More

The vaccine has been developed by Siberia's Vector Institute, which completed early-stage human trials of the vaccine last month. ...Less

The Russian Direct Investment Fund (RDIF), which has backed the development of Sputnik, said in a stateme ...More

The Russian Direct Investment Fund (RDIF), which has backed the development of Sputnik, said in a statement it partnered with the Virchow Group to produce up to 200 million doses of Sputnik a year in India. ...Less

"We demand a public apology from EMA's Christa Wirthumer-Hoche for her negative comments on EU states dir ...More

"We demand a public apology from EMA's Christa Wirthumer-Hoche for her negative comments on EU states directly approving Sputnik V," the vaccine developers wrote on the official Sputnik V Twitter account. "Her comments raise serious questions about possible political interference in the ongoing EMA review," they said. ...Less

President Vladimir Putin has trumpeted the vaccine around the world, and said in March that Russia had si ...More

President Vladimir Putin has trumpeted the vaccine around the world, and said in March that Russia had signed agreements for the production of 700 million doses of Sputnik V vaccine abroad. But Russia had produced just 33 million vaccines as of May 12 and exported fewer than 15 million. ...Less

In September 2020, Dr. Reddy’s and RDIF entered into a partnership to conduct clinical trials of Sputnik ...More

In September 2020, Dr. Reddy’s and RDIF entered into a partnership to conduct clinical trials of Sputnik V vaccine and its distribution in India. As part of the partnership, RDIF shall supply 100 million doses of the vaccine to Dr. Reddy’s upon regulatory approval in India. ...Less

India's move comes as a setback for Russia's plan to roll-out the vaccine even before full trials show ho ...More

India's move comes as a setback for Russia's plan to roll-out the vaccine even before full trials show how well it works, while pushing back its efforts to win approval for the vaccine in the country that leads the world on average number of new infections. ...Less